Objective: Isotretinoin is highly preferred in the treatment of severe and resistant acne, but there are still disagreements about whether it has psychogenic side effects. In this study; we aim to investigate the changes in psychological symptoms before and after the treatment in a group of patients treated with isotretinoin. Material and Methods: A total of 110 patients who had moderate or severe acne, and decided to start isotretinoin treatment, were included. Acne Quality of Life Scale, Beck Depression Inventory (BDI), Beck Suicidal Ideation Scale, and Symptom Check List (SCL-90-R) Psychological Symptom Screening tests were performed and compared before starting treatment and at the 6th month of treatment. Results: In our study, in both the pre-treatment and post-treatment groups, the rate of patients at risk for depression was significantly higher in the group that had severe acne (p<0.05). The scores of psychiatric tests with moderate acne were found to be significantly lower than those with severe acne in all parameters (p<0.05). We have found that somatization, depression, phobic thoughts, and general symptom index scores were significantly higher in women before and after the treatment (p<0.05). Acne treatment was associated with improved quality of life and BDI scores in both male and female patients (p=0.001). SCL-90-R somatization, obsession, depression, sensitivity, anger, and general symptom index scores decreased significantly after the treatment. Conclusion: Our study objectively demonstrated that isotretinoin treatment does not cause depression and psychological symptoms, and even improves depression and psychological symptoms caused by acne and improves the quality of life.
Keywords: Acne; isotretinon; depression
Amaç: İzotretinoin, şiddetli ve dirençli akne tedavisinde oldukça fazla tercih edilmekle birlikte psikojenik yan etkilerinin olup olmadığı konusunda hâlen görüş ayrılıkları bulunmaktadır. Bu çalışmada; izotretinoin ile tedavi edilen bir grup hastada tedavi öncesi ve sonrası psikolojik belirtilerdeki değişiklikleri araştırmayı amaçladık. Gereç ve Yöntemler: Çalışmaya orta veya şiddetli aknesi olan ve izotretinoin tedavisine başlamaya karar veren toplam 110 hasta dâhil edildi. Akne Yaşam Kalitesi Ölçeği, Beck Depresyon Envanteri [Beck Depression Inventory (BDI)], Beck İntihar Düşüncesi Ölçeği ve Belirti Tarama Listesi [Symptom Check List (SCL-90-R)] Psikolojik Belirti Tarama testleri tedaviye başlamadan önce ve tedavinin 6. ayında karşılaştırıldı. Bulgular: Çalışmamızda hem tedavi öncesi hem de tedavi sonrası gruplarda şiddetli aknesi olan grupta depresyon riski taşıyan hasta oranı anlamlı olarak daha yüksekti (p<0,05). Orta derecede aknesi olan hastalarda psikiyatrik test puanları şiddetli aknesi olanlara göre anlamlı olarak düşük bulundu (p<0,05). Kadınlarda somatizasyon, depresyon, fobik düşünceler ve genel semptom indeksi puanlarının tedavi öncesi ve sonrası anlamlı olarak yüksek olduğunu bulduk (p<0,05). Akne tedavisi, hem erkek hem de kadın hastalarda yaşam kalitesi ve BDI skorlarında iyileşme ile ilişkilendirildi (p=0,001). SCL-90-R somatizasyon, obsesyon, depresyon, duyarlılık, öfke ve genel semptom indeks puanları tedavi sonrasında anlamlı olarak azaldı. Sonuç: Çalışmamız, izotretinoin tedavisinin depresyon ve psikolojik belirtilere neden olmadığını, hatta akneye bağlı gelişen depresyon ve psikolojik belirtileri düzelttiğini ve yaşam kalitesini iyileştirdiğini objektif olarak göstermiştir.
Anahtar Kelimeler: Akne; izotretinoin; depresyon
- Hahm BJ, Min SU, Yoon MY, Shin YW, Kim JS, Jung JY, et al. Changes of psychiatric parameters and their relationships by oral isotretinoin in acne patients. J Dermatol. 2009;36(5):255-61. [Crossref] [PubMed]
- Dreno B, Poli F. Epidemiology of acne. Dermatology. 2003;206(1):7-10. [Crossref] [PubMed]
- AlGhofaili FA. Isotretinoin use and risk of depression in acne vulgaris patients in riyadh, Saudi Arabia. Cureus. 2021;13(3):e13680. [Crossref] [PubMed] [PMC]
- Fakour Y, Noormohammadpour P, Ameri H, Ehsani AH, Mokhtari L, Khosrovanmehr N, et al. The effect of isotretinoin (roaccutane) therapy on depression and quality of life of patients with severe acne. Iran J Psychiatry. 2014;9(4):237-40. [PubMed] [PMC]
- Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol. 1998;134(4):454-8. [Crossref] [PubMed]
- Thomas DR. Psychosocial effects of acne. J Cutan Med Surg. 2004;8 Suppl 4:3-5. [Crossref] [PubMed]
- Saitta P, Keehan P, Yousif J, Way BV, Grekin S, Brancaccio R. An update on the presence of psychiatric comorbidities in acne patients, Part 2: Depression, anxiety, and suicide. Cutis. 2011;88(2):92-7. [PubMed]
- Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol. 2001;45(4):515-9. [Crossref] [PubMed]
- Uhlenhake E, Yentzer BA, Feldman SR. Acne vulgaris and depression: a retrospective examination. J Cosmet Dermatol. 2010;9(1):59-63. [Crossref] [PubMed]
- Huang YC, Cheng YC. Isotretinoin treatment for acne and risk of depression: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;76(6):1068-76.e9. Erratum in: J Am Acad Dermatol. 2017. [Crossref] [PubMed]
- Bremner JD, Shearer KD, McCaffery PJ. Retinoic acid and affective disorders: the evidence for an association. J Clin Psychiatry. 2012;73(1):37-50. [Crossref] [PubMed] [PMC]
- Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol. 1999;140(2):273-82. [Crossref] [PubMed]
- Aktan S, Ozmen E, Sanli B. Anxiety, depression, and nature of acne vulgaris in adolescents. Int J Dermatol. 2000;39(5):354-7. [Crossref] [PubMed]
- Yüksel Başak P, Ergin Ş. Akne vulgarisin yaşam kalitesi üzerine etkileri [Effects of acnevulgaris on quality of life]. Turkderm. 2000;34(2):107-9. [Link]
- Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998;139(5):846-50. [Crossref] [PubMed]
- Rubinow DR, Peck GL, Squillace KM, Gantt GG. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol. 1987;17(1):25-32. [Crossref] [PubMed]
- Wysowski DK, Pitts M, Beitz J. Depression and suicide in patients treated with isotretinoin. N Engl J Med. 2001;344(6):460. [Crossref] [PubMed]
- Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol. 2000;136(10):1231-6. [Crossref] [PubMed]
- Cohen J, Adams S, Patten S. No association found between patients receiving isotretinoin for acne and the development of depression in a Canadian prospective cohort. Can J Clin Pharmacol. 2007;14(2):e227-33. [PubMed]
- Chia CY, Lane W, Chibnall J, Allen A, Siegfried E. Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study. Arch Dermatol. 2005;141(5):557-60. [Crossref] [PubMed]
- Golchai J, Khani SH, Heidarzadeh A, Eshkevari SS, Alizade N, Eftekhari H. Comparison of anxiety and depression in patients with acne vulgaris and healthy individuals. Indian J Dermatol. 2010;55(4):352-4. [Crossref] [PubMed] [PMC]
- Tom WL, Friedlander SF. Acne through the ages: case-based observations through childhood and adolescence. Clin Pediatr (Phila). 2008;47(7):639-51. [Crossref] [PubMed]
- Collier CN, Harper JC, Cafardi JA, Cantrell WC, Wang W, Foster KW, et al. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol. 2008;58(1):56-9. Erratum in: J Am Acad Dermatol. 2008;58(5):874. Cafardi, Jennifer A [added]. [Crossref] [PubMed]
- Marqueling AL, Zane LT. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg. 2005;24(2):92-102. [Crossref] [PubMed]
- Webster GF, Leyden JJ, Gross JA. Results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne. J Drugs Dermatol. 2014;13(6):665-70. [PubMed]
- Li C, Chen J, Wang W, Ai M, Zhang Q, Kuang L. Use of isotretinoin and risk of depression in patients with acne: a systematic review and meta-analysis. BMJ Open. 2019;9(1):e021549. Erratum in: BMJ Open. 2019;9(3):e021549corr1. [Crossref] [PubMed] [PMC]
- Azoulay L, Blais L, Koren G, LeLorier J, Bérard A. Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J Clin Psychiatry. 2008;69(4):526-32. [Crossref] [PubMed]
- Kubota Y, Shirahige Y, Nakai K, Katsuura J, Moriue T, Yoneda K. Community-based epidemiological study of psychosocial effects of acne in Japanese adolescents. J Dermatol. 2010;37(7):617-22. [Crossref] [PubMed]
- Cotterill JA, Cunliffe WJ. Suicide in dermatological patients. Br J Dermatol. 1997;137(2):246-50. [Crossref] [PubMed]
.: Process List